Vikas Sinha

CIK 1337845 · Chief Financial Officer · last filed 2026-04-20

Vikas Sinha is a Chief Financial Officer who has filed 128 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider sold $516.1K of SRRK on Apr 20, 2026. Across all open-market trades the lifetime net is −$4.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.39M

Companies

3

Total Filings

128

Lifetime Open-Market Net

-$4.66M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SRRK Chief Financial Officer 619,856 $44.18 $27.39M -$1.23M 5 2026-04-20
Verona Pharma plc (VRNA) Delisted Director 0 $106.91 $0 -$3.18M 12 2025-10-08
Kalaris Therapeutics, Inc. (ALVR) Delisted See Remarks 774,118 $9.81 $7.59M -$246.5K 40 2025-02-24

Recent Filings

128 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-04-20 SRRK Sell (S) −10,410 -$516.1K EDGAR
2026-02-11 SRRK Grant (A) +47,021 $0 EDGAR
2026-01-15 SRRK Sell (S) −16,755 -$715.4K EDGAR
2025-10-08 Verona Pharma plc (VRNA) Delisted Mixed −94,112 $0 EDGAR
2025-08-05 Verona Pharma plc (VRNA) Delisted Mixed +19,672 -$56.9K EDGAR
2025-05-22 Verona Pharma plc (VRNA) Delisted Mixed -$1.20M EDGAR
2025-05-22 Verona Pharma plc (VRNA) Delisted Mixed -$1.42M EDGAR
2025-05-06 SRRK Grant (A) $0 EDGAR
2025-05-01 Verona Pharma plc (VRNA) Delisted Mixed -$150.3K EDGAR
2025-04-29 SRRK Grant (A) +600,000 $0 EDGAR
Showing 110 of 128
Page 1 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.